John Hancock US High Dividend ETF
JHDV
2 hedge funds and large institutions have $6.62M invested in John Hancock US High Dividend ETF in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 4 closing their positions.
54% less capital invested
Capital invested by funds: $14.5M → $6.62M (-$7.86M)
67% less funds holding
Funds holding: 6 → 2 (-4)
75.96% less ownership
Funds ownership: 162.93% → 86.98% (-76%)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$6.79M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$429K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$280K |
| 4 |
Goldman Sachs
New York
|
-$213K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.09K |
JHDV Hedge Fund Activity: Q1 2025 in Review
2 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in John Hancock US High Dividend ETF (JHDV) for Q1 2025, worth a combined $6.62M — down 54% from $14.5M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of JHDV and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $6.79M.
- 2 institutional investors held John Hancock US High Dividend ETF (JHDV) as of Q1 2025, down from 6 in Q4 2024.
- Funds reported $6.62M of John Hancock US High Dividend ETF stock for Q1 2025, down 54% quarter-over-quarter.
- 0 funds opened new John Hancock US High Dividend ETF positions in Q1 2025 and 4 closed out, a net change of -4 holders.
- The largest John Hancock US High Dividend ETF seller in Q1 2025 was Manulife (Manufacturers Life Insurance), an estimated $6.79M sold.
Based on aggregated 13F filings for Q1 2025.